Literature DB >> 27571186

Hyperandrogenism Accompanies Increased Intra-Abdominal Fat Storage in Normal Weight Polycystic Ovary Syndrome Women.

Daniel A Dumesic1, Alin L Akopians1, Vanessa K Madrigal1, Emmanuel Ramirez1, Daniel J Margolis1, Manoj K Sarma1, Albert M Thomas1, Tristan R Grogan1, Rasha Haykal1, Tery A Schooler1, Bette L Okeya1, David H Abbott1, Gregorio D Chazenbalk1.   

Abstract

CONTEXT: Normal weight polycystic ovary syndrome (PCOS) women may have altered adipose structure-function underlying metabolic dysfunction.
OBJECTIVE: This study examines whether adipose structure-functional changes exist in normal weight PCOS women and correlate with hyperandrogenism and/or hyperinsulinemia.
DESIGN: This is a prospective cohort study.
SETTING: The setting was an academic medical center. PATIENTS: Six normal weight PCOS women and 14 age- and body mass index-matched normoandrogenic ovulatory (NL) women were included. INTERVENTION(S): All women underwent circulating hormone and metabolic measurements; frequently sampled intravenous glucose tolerance testing; total body dual-energy x-ray absorptiometry; abdominal magnetic resonance imaging; and SC abdominal fat biopsy. MAIN OUTCOME MEASURE(S): Circulating hormones and metabolites, body fat and its distribution, and adipocyte size were compared between PCOS and NL women, and were correlated with each other in all women.
RESULTS: Circulating LH and androgen levels were significantly greater in PCOS than NL women, as were fasting insulin levels, pancreatic β-cell responsiveness to glucose, and total abdominal fat mass. Intra-abdominal fat mass also was significantly increased in PCOS women and was positively correlated with circulating androgen, fasting insulin, triglyceride, and non-high-density lipoprotein cholesterol levels in all women. SC abdominal fat mass was not significantly increased in PCOS women, but contained a greater proportion of small SC abdominal adipocytes that positively correlated with serum androgen levels in all women.
CONCLUSION: Hyperandrogenism in normal weight PCOS women is associated with preferential intra-abdominal fat deposition and an increased population of small SC abdominal adipocytes that could constrain SC adipose storage and promote metabolic dysfunction.

Entities:  

Mesh:

Year:  2016        PMID: 27571186      PMCID: PMC5095243          DOI: 10.1210/jc.2016-2586

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  53 in total

1.  Mechanisms behind lipolytic catecholamine resistance of subcutaneous fat cells in the polycystic ovarian syndrome.

Authors:  Gary Faulds; Mikael Rydén; Ingvar Ek; Hans Wahrenberg; Peter Arner
Journal:  J Clin Endocrinol Metab       Date:  2003-05       Impact factor: 5.958

2.  Referral bias in defining the phenotype and prevalence of obesity in polycystic ovary syndrome.

Authors:  Uche Ezeh; Bulent O Yildiz; Ricardo Azziz
Journal:  J Clin Endocrinol Metab       Date:  2013-03-28       Impact factor: 5.958

Review 3.  Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome--an allostatic perspective.

Authors:  Sam Virtue; Antonio Vidal-Puig
Journal:  Biochim Biophys Acta       Date:  2010-01-06

4.  Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp.

Authors:  Nigel K Stepto; Samantha Cassar; Anju E Joham; Samantha K Hutchison; Cheryce L Harrison; Rebecca F Goldstein; Helena J Teede
Journal:  Hum Reprod       Date:  2013-01-12       Impact factor: 6.918

5.  Insulin resistance in polycystic ovary syndrome: decreased expression of GLUT-4 glucose transporters in adipocytes.

Authors:  D Rosenbaum; R S Haber; A Dunaif
Journal:  Am J Physiol       Date:  1993-02

6.  Heterogeneity in beta cell activity, hepatic insulin clearance and peripheral insulin sensitivity in women with polycystic ovary syndrome.

Authors:  M Ciampelli; A M Fulghesu; F Cucinelli; V Pavone; A Caruso; S Mancuso; A Lanzone
Journal:  Hum Reprod       Date:  1997-09       Impact factor: 6.918

7.  Impaired preadipocyte differentiation into adipocytes in subcutaneous abdominal adipose of PCOS-like female rhesus monkeys.

Authors:  Erica Keller; Gregorio D Chazenbalk; Paul Aguilera; Vanessa Madrigal; Tristan Grogan; David Elashoff; Daniel A Dumesic; David H Abbott
Journal:  Endocrinology       Date:  2014-04-15       Impact factor: 4.736

8.  Relation of intra-abdominal fat distribution to metabolic disorders in nonobese patients with polycystic ovary syndrome.

Authors:  Basak Yildirim; Nuran Sabir; Babur Kaleli
Journal:  Fertil Steril       Date:  2003-06       Impact factor: 7.329

9.  Pituitary desensitization to gonadotropin-releasing hormone increases abdominal adiposity in hyperandrogenic anovulatory women.

Authors:  D A Dumesic; D H Abbott; J R Eisner; R R Herrmann; J E Reed; T J Welch; M D Jensen
Journal:  Fertil Steril       Date:  1998-07       Impact factor: 7.329

10.  Enhanced proportion of small adipose cells in insulin-resistant vs insulin-sensitive obese individuals implicates impaired adipogenesis.

Authors:  T McLaughlin; A Sherman; P Tsao; O Gonzalez; G Yee; C Lamendola; G M Reaven; S W Cushman
Journal:  Diabetologia       Date:  2007-06-05       Impact factor: 10.122

View more
  53 in total

Review 1.  Mechanisms for Sex Differences in Energy Homeostasis.

Authors:  Chunmei Wang; Yong Xu
Journal:  J Mol Endocrinol       Date:  2019-02-01       Impact factor: 5.098

2.  Precocious subcutaneous abdominal stem cell development to adipocytes in normal-weight women with polycystic ovary syndrome.

Authors:  Samantha C Fisch; Ariella Farzan Nikou; Elizabeth A Wright; Julia D Phan; Karen L Leung; Tristan R Grogan; David H Abbott; Gregorio D Chazenbalk; Daniel A Dumesic
Journal:  Fertil Steril       Date:  2018-12       Impact factor: 7.329

3.  Chronic hyperandrogenemia and western-style diet beginning at puberty reduces fertility and increases metabolic dysfunction during pregnancy in young adult, female macaques.

Authors:  C V Bishop; R L Stouffer; D L Takahashi; E C Mishler; M C Wilcox; O D Slayden; C A True
Journal:  Hum Reprod       Date:  2018-04-01       Impact factor: 6.918

4.  Neuronal androgen receptor: Molecular gateway to polycystic ovary syndrome?

Authors:  David H Abbott
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-04       Impact factor: 11.205

5.  Endocrine-Metabolic Dysfunction in Polycystic Ovary Syndrome: an Evolutionary Perspective.

Authors:  Daniel A Dumesic; David H Abbott; Smriti Sanchita; Gregorio D Chazenbalk
Journal:  Curr Opin Endocr Metab Res       Date:  2020-03-09

Review 6.  Hyperandrogenic origins of polycystic ovary syndrome - implications for pathophysiology and therapy.

Authors:  David H Abbott; Daniel A Dumesic; Jon E Levine
Journal:  Expert Rev Endocrinol Metab       Date:  2019-02-15

7.  Adipose Insulin Resistance in Normal-Weight Women With Polycystic Ovary Syndrome.

Authors:  Daniel A Dumesic; Julia D Phan; Karen L Leung; Tristan R Grogan; Xiangmiang Ding; Xinmin Li; Luis R Hoyos; David H Abbott; Gregorio D Chazenbalk
Journal:  J Clin Endocrinol Metab       Date:  2019-06-01       Impact factor: 5.958

Review 8.  Mechanisms of intergenerational transmission of polycystic ovary syndrome.

Authors:  Daniel A Dumesic; Luis R Hoyos; Gregorio D Chazenbalk; Rajanigandha Naik; Vasantha Padmanabhan; David H Abbott
Journal:  Reproduction       Date:  2020-01       Impact factor: 3.906

9.  Chronic combined hyperandrogenemia and western-style diet in young female rhesus macaques causes greater metabolic impairments compared to either treatment alone.

Authors:  C A True; D L Takahashi; S E Burns; E C Mishler; K R Bond; M C Wilcox; A R Calhoun; L A Bader; T A Dean; N D Ryan; O D Slayden; J L Cameron; R L Stouffer
Journal:  Hum Reprod       Date:  2017-09-01       Impact factor: 6.918

10.  Combined androgen excess and Western-style diet accelerates adipose tissue dysfunction in young adult, female nonhuman primates.

Authors:  Oleg Varlamov; Cecily V Bishop; Mithila Handu; Diana Takahashi; Sathya Srinivasan; Ashley White; Charles T Roberts
Journal:  Hum Reprod       Date:  2017-09-01       Impact factor: 6.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.